Knowledge of pre-exposure prophylaxis (PrEP) for HIV prevention among men who have sex with men in Denver, Colorado

AIDS and Behavior

Volumn 18, Issue SUPPL. 3, 2014, Pages

  Al Tayyib, Alia A ^a,b   Thrun, Mark W ^a,c   Haukoos, Jason S ^b,d   Walls, N Eugene ^e  

^a DENVER PUBLIC HEALTH   (United States)

^b Food Science and Human Nutrition   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^d DENVER HEALTH AND HOSPITAL AUTHORITY   (United States)

^e UNIVERSITY OF DENVER   (United States)

Author keywords

Behavioral surveillance; Men who have sex with men; Pre exposure prophylaxis

Indexed keywords

ADULT; ATTITUDE TO HEALTH; BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM; COLORADO; CONDOM; HIV INFECTIONS; HUMAN; INTERVIEW; MALE; MALE HOMOSEXUALITY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PRIMARY PREVENTION; PROCEDURES; PSYCHOLOGY; QUESTIONNAIRE; SEXUALITY; SOCIOECONOMICS; STATISTICS AND NUMERICAL DATA; UNSAFE SEX; UTILIZATION; YOUNG ADULT;

ADULT; BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM; COLORADO; CONDOMS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PRIMARY PREVENTION; SEXUAL PARTNERS; SOCIOECONOMIC FACTORS; SURVEYS AND QUESTIONNAIRES; UNSAFE SEX; YOUNG ADULT;

EID: 84898899127     PISSN: 10907165     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10461-013-0553-6     Document Type: Article

References (31)

1. Cohen MS, Holmes C, Padian N, Wolf M, Hirnschall G, Lo YR, et al. HIV treatment as prevention: how scientific discovery occurred and translated rapidly into policy for the global response. Health Aff (Millwood). 2012;31(7):1439-49.
2. Flash C, Krakower D, Mayer KH. The promise of antiretrovirals for HIV prevention. Curr Infect Dis Rep. 2012;14(2):185-93.
3. Person AK, Hicks CB. Pre-exposure prophylaxis - one more tool for HIV prevention. Curr HIV Res. 2012;10(2):117-22.
4. Kashuba AD, Patterson KB, Dumond JB, Cohen MS. Pre-exposure prophylaxis for HIV prevention: how to predict success. Lancet. 2012;379(9835):2409-11.
5. Abdool Karim SS. Top stories of 2008. The prospect of PrEP. AIDS Clin Care. 2009;21(1):6.
6. Cohen MS, Gay C, Kashuba AD, Blower S, Paxton L. Narrative review: antiretroviral therapy to prevent the sexual transmission of HIV-1. Ann Intern Med. 2007;146(8):591-601.
7. Youle M, Wainberg MA. Pre-exposure chemoprophylaxis (PREP) as an HIV prevention strategy. J Int Assoc Physicians AIDS Care (Chic). 2003;2(3):102-5.
8. Thigpen MC, Kebaabetswe PM, Paxton LA, Smith DK, Rose CE, Segolodi TM, et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med. 2012;367(5):423-34.
9. Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367(5):399-410.
10. Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587-99.
11. U.S. Food and Drug Administration. FDA approves first drug for reducing risk of sexually acquired HIV infection. 2012 [cited 30 Oct 2012]. Available from: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm312210.htm.
12. CDC. Interim guidance: preexposure prophylaxis for the prevention of HIV infection in men who have sex with men. MMWR Morb Mortal Wkly Rep. 2011;60(03):65-8.
13. CDC. Interim guidance for clinicians considering the use of preexposure prophylaxis for the prevention of HIV infection in heterosexually active adults. MMWR Morb Mortal Wkly Rep. 2012;61(31):586-9.
14. CDC. Update to interim guidance for preexposure prophylaxis (PrEP) for the prevention of HIV infection: PrEP for injecting drug users. MMWR Morb Mortal Wkly Rep. 2013;62(23):463-5.
15. Fisher M. Preexposure prophylaxis for HIV infection: it's not as easy as ABC. Curr Opin Infect Dis. 2007;20(1):1-2.
16. Buchbinder SP, Liu A. Pre-exposure prophylaxis and the promise of combination prevention approaches. AIDS Behav. 2011;15(Suppl 1):S72-9.
17. Liu AY, Kittredge PV, Vittinghoff E, Raymond HF, Ahrens K, Matheson T, et al. Limited knowledge and use of HIV post- and pre-exposure prophylaxis among gay and bisexual men. J Acquir Immune Defic Syndr. 2008;47(2):241-7.
18. Voetsch AC, Heffelfinger JD, Begley EB, Jafa-Bhushan K, Sullivan PS. Knowledge and use of preexposure and postexposure prophylaxis among attendees of Minority Gay Pride events, 2005 through 2006. J Acquir Immune Defic Syndr. 2007;46(3):378-80.
19. Mimiaga MJ, Case P, Johnson CV, Safren SA, Mayer KH. Preexposure antiretroviral prophylaxis attitudes in high-risk Boston area men who report having sex with men: limited knowledge and experience but potential for increased utilization after education. J Acquir Immune Defic Syndr. 2009;50(1):77-83.
20. Kellerman SE, Hutchinson AB, Begley EB, Boyett BC, Clark HA, Sullivan P. Knowledge and use of HIV pre-exposure prophylaxis among attendees of minority gay pride events, 2004. J Acquir Immune Defic Syndr. 2006;43(3):376-7.
21. Mansergh G, Koblin BA, Colfax GN, McKirnan DJ, Flores SA, Hudson SM. Preefficacy use and sharing of antiretroviral medications to prevent sexually-transmitted HIV infection among US men who have sex with men. J Acquir Immune Defic Syndr. 2010;55(2):e14-6.
22. Golub SA, Kowalczyk W, Weinberger CL, Parsons JT. Preexposure prophylaxis and predicted condom use among high-risk men who have sex with men. J Acquir Immune Defic Syndr. 2010;54(5):548-55.
23. Gallagher KM, Sullivan PS, Lansky A, Onorato IM. Behavioral surveillance among people at risk for HIV infection in the U.S.: the National HIV Behavioral Surveillance System. Public Health Rep. 2007;122(Suppl 1):32-8.
24. Karon J. The analysis of time-location sampling data. American Statistical Association Section of Survey Research Methods 2005, Minneapolis; 2005. p. 3180-3186.
25. Krakower DS, Mimiaga MJ, Rosenberger JG, Novak DS, Mitty JA, White JM, et al. Limited awareness and low immediate uptake of pre-exposure prophylaxis among men who have sex with men using an internet social networking site. PLoS One. 2012;7(3):e33119.
26. Galindo GR, Walker JJ, Hazelton P, Lane T, Steward WT, Morin SF, et al. Community member perspectives from transgender women and men who have sex with men on pre-exposure prophylaxis as an HIV prevention strategy: implications for implementation. Implement Sci. 2012;7:116.
27. Rucinski KB, Mensah NP, Sepkowitz KA, Cutler BH, Sweeney MM, Myers JE. Knowledge and use of pre-exposure prophylaxis among an online sample of young men who have sex with men in New York City. AIDS Behav. 2013;17(6):2180-4.
28. Saberi P, Gamarel KE, Neilands TB, Comfort M, Sheon N, Darbes LA, et al. Ambiguity, ambivalence, and apprehensions of taking HIV-1 pre-exposure prophylaxis among male couples in San Francisco: a mixed methods study. PLoS One. 2012;7(11):e50061.
29. Underhill K, Morrow KM, Operario D, Mayer KH. Could FDA approval of pre-exposure prophylaxis make a difference? A qualitative study of PrEP acceptability and FDA perceptions among men who have sex with men. AIDS Behav. 2013. doi: 10.1007/s10461-013-0498-9.
30. Eisingerich AB, Wheelock A, Gomez GB, Garnett GP, Dybul MR, Piot PK. Attitudes and acceptance of oral and parenteral HIV preexposure prophylaxis among potential user groups: a multinational study. PLoS One. 2012;7(1):e28238.
31. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493-505.